C. Teghom

发表

[Renal carcinoma: point on treatment of brain metastasis].

P. Giraud, S. Oudard, P. Menei, 2012, Bulletin du cancer.

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis

J. Patard, D. Lambrechts, J. Zucman‐Rossi, 2014, Acta oncologica.

Prognostic impact of baseline serum C‐reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib

B. van Calster, J. Zucman‐Rossi, R. Paridaens, 2014, BJU International.

Brain Metastasis from Renal Carcinoma: Locoregional and Systemic Treatments

P. Giraud, S. Oudard, C. Teghom, 2015 .

Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumab

H. Moch, S. Oudard, B. Beuselinck, 2012, The American journal of case reports.

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.

A. Ravaud, S. Culine, J. Machiels, 2015, European journal of cancer.

Renal malacoplakia: Case report of a differential diagnosis for renal cell carcinoma

J. Correas, S. Oudard, L. Fournier, 2012, The American journal of case reports.

[Bellini tumours].

S. Oudard, F. Scotté, C. Teghom, 2011, Bulletin du cancer.

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.

A. Ravaud, S. Culine, J. Machiels, 2015, European journal of cancer.